CannBioRx Issuance Of Capital Stock from 2010 to 2024

ATNFW Stock  USD 0.01  0  22.64%   
CannBioRx Life Issuance Of Capital Stock yearly trend continues to be fairly stable with very little volatility. Issuance Of Capital Stock will likely drop to about 13 M in 2024. During the period from 2010 to 2024, CannBioRx Life Issuance Of Capital Stock regression line of quarterly data had mean square error of 40.2 T and geometric mean of  1,936,041. View All Fundamentals
 
Issuance Of Capital Stock  
First Reported
2010-12-31
Previous Quarter
18.5 M
Current Value
13 M
Quarterly Volatility
8.2 M
 
Credit Downgrade
 
Yuan Drop
 
Covid
Check CannBioRx Life financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among CannBioRx Life's main balance sheet or income statement drivers, such as Interest Expense of 42.59, Selling General Administrative of 7.6 M or Interest Income of 0.0, as well as many indicators such as Price To Sales Ratio of 0.0, Dividend Yield of 0.0 or Days Sales Outstanding of 0.0. CannBioRx financial statements analysis is a perfect complement when working with CannBioRx Life Valuation or Volatility modules.
  
Check out the analysis of CannBioRx Life Correlation against competitors.

Latest CannBioRx Life's Issuance Of Capital Stock Growth Pattern

Below is the plot of the Issuance Of Capital Stock of CannBioRx Life Sciences over the last few years. It is CannBioRx Life's Issuance Of Capital Stock historical data analysis aims to capture in quantitative terms the overall pattern of either growth or decline in CannBioRx Life's overall financial position and show how it may be relating to other accounts over time.
Issuance Of Capital Stock10 Years Trend
Slightly volatile
   Issuance Of Capital Stock   
       Timeline  

CannBioRx Issuance Of Capital Stock Regression Statistics

Arithmetic Mean5,467,702
Geometric Mean1,936,041
Coefficient Of Variation150.00
Mean Deviation6,499,395
Median1,132,676
Standard Deviation8,201,389
Sample Variance67.3T
Range26.6M
R-Value0.67
Mean Square Error40.2T
R-Squared0.45
Significance0.01
Slope1,223,992
Total Sum of Squares941.7T

CannBioRx Issuance Of Capital Stock History

202413 M
202318.5 M
202212.5 M
202126.7 M
202072.5 K

About CannBioRx Life Financial Statements

CannBioRx Life investors use historical fundamental indicators, such as CannBioRx Life's Issuance Of Capital Stock, to determine how well the company is positioned to perform in the future. Understanding over-time patterns can help investors decide on long-term investments in CannBioRx Life. Please read more on our technical analysis and fundamental analysis pages.
Last ReportedProjected for Next Year
Issuance Of Capital Stock18.5 M13 M

Also Currently Popular

Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.

Additional Tools for CannBioRx Stock Analysis

When running CannBioRx Life's price analysis, check to measure CannBioRx Life's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy CannBioRx Life is operating at the current time. Most of CannBioRx Life's value examination focuses on studying past and present price action to predict the probability of CannBioRx Life's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move CannBioRx Life's price. Additionally, you may evaluate how the addition of CannBioRx Life to your portfolios can decrease your overall portfolio volatility.